Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-22,564
Closed -$769K 645
2017
Q1
$769K Sell
22,564
-1,640
-7% -$55K 0.02% 395
2016
Q4
$775K Buy
24,204
+4,835
+25% +$155K 0.02% 400
2016
Q3
$655K Buy
19,369
+1,365
+8% +$47.3K 0.02% 447
2016
Q2
$634K Buy
18,004
+100
+0.6% +$3.53K 0.02% 423
2016
Q1
$542K Sell
17,904
-170
-0.9% -$4.67K 0.01% 434
2015
Q4
$574K Hold
18,074
0.01% 432
2015
Q3
$530K Sell
18,074
-1,050
-5% -$35.5K 0.02% 512
2015
Q2
$749K Buy
19,124
+730
+4% +$28.5K 0.03% 353
2015
Q1
$687K Buy
18,394
+8,010
+77% +$304K 0.03% 373
2014
Q4
$394K Buy
10,384
+2,584
+33% +$94.4K 0.02% 390
2014
Q3
$278K Buy
7,800
+850
+12% +$33.4K 0.01% 484
2014
Q2
$293K Buy
+6,950
New +$272K 0.01% 487

Other funds holding AVNT

Boston Advisors's AVNT Position: Q2 2017 in Review

Boston Advisors sold out of Avient (AVNT) in Q2 2017, closing a stake of 22,564 shares — an estimated $769K sold.

Boston Advisors first reported a position in AVNT in Q2 2014 and held it in 12 quarters. The position peaked at $775K in Q4 2016. 259 funds tracked by Wall St. Rank hold AVNT as of Q2 2017.

  • Boston Advisors reported no remaining Avient position as of Q2 2017 after selling out during the quarter.
  • Boston Advisors sold 22,564 Avient shares in Q2 2017, an estimated $769K.
  • Boston Advisors first reported a position in Avient in Q2 2014 and held it in 12 quarters.
  • Boston Advisors's Avient position peaked at $775K in Q4 2016.
  • 259 funds tracked by Wall St. Rank held Avient as of Q2 2017.

Based on Boston Advisors's 13F filing for Q2 2017, filed 25 Jul 2017.